Medicine for treating lung cancer

Abstract

The invention relates to a medicine for treating lung cancer, which is prepared from the following raw medicinal materials in parts by weight: 7 parts of radix peucedani, 12 parts of agrimony, 10 parts of salvia chinensis, 7 parts of sago seeds, 30 parts of dicliptera, 6 parts of pimpinella coriacea, 12 parts of schefflera arboricola and 22 parts of colocasia tonoimo. According to the medicine provided by the invention, the radix peucedani has the effects of dispelling wind and heat from the body as well as depressing qi and dissipating phlegm; the agrimony has the effects of stopping bleeding by astringency as well as relieving dysentery and killing parasites; the salvia chinensis has the effects of promoting blood circulation to remove blood stasis, clearing away heat and promoting diuresis as well as removing stasis and eliminating swelling; the sago seeds have the effects of eliminating dampness, strengthening the spleen and stomach as well as expelling phlegm and arresting coughing; the dicliptera has the effects of removing pathogenic heat from blood as well as promoting diuresis and relieving toxicity; the pimpinella coriacea has the effects of warming the middle-jiao and dispelling cold, dispelling wind and eliminating dampness as well as promoting blood circulation to restore menstrual flow; the schefflera arboricola has the effects of dispersing pathogenic wind and alleviating pain as well as promoting blood circulation and eliminating swelling; and the colocasia tonoimo has the effects of removing stasis and eliminating swelling as well as dispersing pathogenic wind and relieving toxicity. All medicines are combined for use so as to achieve the effects of nourishing yin and moisturizing the lung, removing pathogenic heat and removing stasis, eliminating dampness and resolving phlegm as well as removing stasis. Clinical experiments prove that the medicine provided by the invention can be used for safely and effectively treating the lung cancer.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating lung cancer. Background technique [0002] Lung cancer, or bronchial lung cancer, originates from the bronchial mucosa and is the most common primary malignant tumor of the lung. The clinical manifestations depend on the location of the cancer and whether there are complications. Generally, there is no manifestation in the early stage, and respiratory symptoms appear in the late stage. Often complicated by atelectasis, pulmonary suppurative infection, and metastatic cancer in other organs. Lung cancer is one of the malignant tumors with the fastest increasing morbidity and mortality and the greatest threat to the health and life of the population. In the past 50 years, many countries have reported that the morbidity and mortality of lung cancer have increased significantly. The incidence and mortality of lung cancer in men rank first among all malignant ...

AI Technical Summary

Problems solved by technology

The mortality rate of this disease is high, and the current treatment effect is not satisfactory

Images